Skip to main content
Updating results


  • Updated

Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment.

  • Updated

Answer: The Food and Drug Administration said it granted approval to a drug from Biogen based on clinical research results that seemed “reasonably likely” to benefit Alzheimer’s patients.

  • Updated

Answer: They will likely request some documentation first that the patient needs the drug. Many plans will require doctors to submit records and other paperwork justifying the treatment before they agree to cover it.

Jillian Gottschalk loved to hear the stories her grandmother, a nurse, told her about her job.

Jack Daniel knows people chuckle when they hear his name.

Get up-to-the-minute news sent straight to your device.


Breaking News

News Alert